Meneghetti Jéssica Kleinkauff, Pedrotti Mirela Tschiedel, Coimbra Isabel Meneghetti, da Cunha-Filho João Sabino Lahorgue
Postgraduate Program in Medical Sciences, Federal University of Rio Grande do Sul, Rua Ramiro Barcelos 2350/1124, Porto Alegre, RS, CEP:90035-903, Brazil.
Medical School, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.
Reprod Sci. 2024 Dec;31(12):3613-3623. doi: 10.1007/s43032-024-01701-w. Epub 2024 Oct 2.
This study aimed to systematically review existing randomized clinical trials on the effect of dietary interventions on endometriosis. A search was performed on the Cochrane Central Register of Controlled Trials (CENTRAL), Cumulative Index to Nursing and Allied Health Literature (CINAHL), Clinical Trials, EMBASE, PubMed, Lilacs, and Cielo databases. The search terms were used: "endometriosis", "endometrioma", "diet", "supplements" and "nutrition". Electronic literature searches through databases yielded 866 publications. Two authors performed The study selection independently (and blinded), and disagreements were discussed. Eleven RCTs were included in the systematic review, with 716 women randomized. Most studies reported a positive effect on endometriosis pain scores; however, they were characterized by moderate or high-risk bias. Of these, six RCTs, including 457 women with endometriosis, were included in the meta-analysis. Compared with Placebo, antioxidant use was associated with a reduction in dysmenorrhea (mean difference - 1.95 [CI 95%, -3.78 to -0.13]. Supplementation was not significant for reducing chronic pelvic pain (mean difference - 2.22 [95% CI, -4.99 to 0.55] and dyspareunia (MD - 2.56 [95% CI, - 5. 22 to 0.10]. Both analyses showed a high degree of heterogeneity. Moreover, studies with low risk of bias did not show significant results compared to those on Placebo. The effects of nutrient compounds seem to have the potential to reduce pain in women with endometriosis, mainly to reduce dysmenorrhea. However, the available studies present high heterogeneity and moderate/high risk of bias. More randomized clinical trials are needed to accurately determine dietary interventions' short- and long-term efficacy and safety in managing endometriosis pain.
本研究旨在系统评价现有关于饮食干预对子宫内膜异位症影响的随机临床试验。我们在Cochrane对照试验中央注册库(CENTRAL)、护理学与健康相关文献累积索引(CINAHL)、临床试验库、EMBASE、PubMed、Lilacs和Cielo数据库中进行了检索。检索词使用了:“子宫内膜异位症”“子宫内膜瘤”“饮食”“补充剂”和“营养”。通过数据库进行的电子文献检索共得到866篇出版物。两名作者独立(且盲法)进行研究筛选,如有分歧则进行讨论。11项随机对照试验被纳入该系统评价,共有716名女性被随机分组。大多数研究报告了对子宫内膜异位症疼痛评分有积极影响;然而,这些研究存在中度或高度偏倚风险。其中,6项随机对照试验(包括457名患有子宫内膜异位症的女性)被纳入荟萃分析。与安慰剂相比,使用抗氧化剂与痛经减轻相关(平均差值-1.95 [95%置信区间,-3.78至-0.13])。补充剂对减轻慢性盆腔疼痛(平均差值-2.22 [95%置信区间,-4.99至0.55])和性交困难(平均差值-2.56 [95%置信区间,-5.22至0.10])并不显著。两项分析均显示高度异质性。此外,与安慰剂组的研究相比,低偏倚风险的研究未显示出显著结果。营养化合物似乎有可能减轻子宫内膜异位症女性的疼痛,主要是减轻痛经。然而,现有研究存在高度异质性和中度/高度偏倚风险。需要更多的随机临床试验来准确确定饮食干预在控制子宫内膜异位症疼痛方面的短期和长期疗效及安全性。